Founded in 2015, Gaudium IVF is a leader in In Vitro Fertilization (IVF) treatments across India. Operating on a hub-and-spoke model, the company has 30+ locations including 7 major hubs in Delhi, Mumbai, Bengaluru, Patna, and more.
Gaudium IVF & Women Health Ltd IPO
Book Build Issue | Health Care Services | BSE & NSE Listing
| Event | Date |
|---|---|
| IPO Opens | Friday, Feb 20, 2026 |
| IPO Closes | Tuesday, Feb 24, 2026 |
| Allotment Basis | Wednesday, Feb 25, 2026 |
| Refund Initiation | Wednesday, Feb 25, 2026 |
| Credit of Shares to Demat | Thursday, Feb 26, 2026 |
| Listing Date | Friday, Feb 27, 2026 |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 189 | ₹14,931 |
| Retail (Max) | 13 | 2,457 | ₹1,94,103 |
| S-HNI (Min) | 14 | 2,646 | ₹2,09,034 |
| S-HNI (Max) | 66 | 12,474 | ₹9,85,446 |
| B-HNI (Min) | 67 | 12,663 | ₹10,00,377 |
Amounts in ₹ Crores
| Period Ended | Assets | Revenue | PAT | EBITDA | Net Worth |
|---|---|---|---|---|---|
| 30-Sep-2025 | 106.62 | 49.75 | 12.51 | 18.95 | 58.85 |
| 31-Mar-2025 | 88.51 | 70.96 | 19.13 | 28.63 | 46.30 |
| 31-Mar-2024 | 51.01 | 48.15 | 10.32 | 19.27 | 26.99 |
| 31-Mar-2023 | 36.63 | 44.26 | 13.53 | 20.07 | 22.73 |
Key Performance Indicators (KPI)
ROE: 41.31% (FY25)
ROCE: 39.70% (FY25)
Debt/Equity: 0.38 (Sep-25)
PAT Margin: 26.96% (FY25)
P/E Ratio (Post-Issue): 22.99x
Price to Book Value: 10.48
Issue Structure
Total Issue: ₹165.00 Cr
Fresh Issue: ₹90.00 Cr (1.14 Cr Shares)
Offer for Sale: ₹75.00 Cr (0.95 Cr Shares)
Face Value: ₹5 per share
Promoter Holding: 99.99% (Pre) → 71.30% (Post)
Founded in 2015, Gaudium IVF is a leader in In Vitro Fertilization (IVF) treatments across India. Operating on a hub-and-spoke model, the company has 30+ locations including 7 major hubs in Delhi, Mumbai, Bengaluru, Patna, and more.
Specializations: IVF, ICSI, IUI, Male Infertility, and high-risk pregnancy management. They serve a global clientele from the US, UK, Canada, and Africa.
Core Strengths: Asset-light business model, Expert medical team, and Next-gen INTEGRA Ti labs.
- Expansion: ₹50.00 Cr for setting up new IVF Centers.
- Debt Repayment: ₹20.00 Cr for clearing outstanding loans.
- Corporate Purpose: General business growth and brand building.
Address: Janak Puri, New Delhi
Email: compliance@gaudiumivfcentre.com